Objective: To investigate how the ulcerative colitis (UC) be treated with Chinese herbal medicines (CHM), using Chinese medicine (CM) pattern (zheng) identification, in the current clinical practice.
Methods: A total of 7 electronic databases were systematically searched for UC clinical studies with CHM interventions (including single herbs and CHM formulas) published in English and Chinese from the date of their inception to November 25, 2020. Descriptive statistics were adopted to demonstrate the characteristics of study design, and to collate the commonly CM patterns of UC and frequently used CHM herbs and formulas. Further, IBM SPSS Modeler 18.0 and Cytoscape 3.7.1 software were used to analyze and visualize the associations between different categories of CHM and their zheng indications.
Results: A total of 2311 articles were included in this study, of which most (> 90%) were RCTs with CHM formulas. The most common zheng of UC was Large intestine dampness-heat, while the basic type of CM patten was Spleen deficiency. The most frequently used classical formula was Bai-Tou-Weng-Tang, followed by Shen-Ling-Bai-Zhu-San, and the commonly used proprietary CHM was Xi-Lei-San (enema). Sulfasalazine and Mesalazine are commonly used as concomitant western medicines. The most frequently used single medicinals were Huang Lian and Bai Zhu, which also identified as the core herbs for different CM patterns.
Conclusion: This study examined the application of CHM interventions for UC and summarized their characteristics in clinical practice. These data indicated there were limited information about the safety assessment of CHM formulas and further RCTs including CM pattern(s) with strict design are necessary.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981751 | PMC |
| http://dx.doi.org/10.1186/s13020-022-00591-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chinese Herbal Medicine for Irritable Bowel Syndrome: A Perspective of Local Immune Actions.
Am J Chin Med
December 2024
College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P. R. China.
Irritable bowel syndrome (IBS) is the functional gastrointestinal disorder, characterized by abdominal pain and altered bowel habits. The interest in intestinal immune activation as a potential disease mechanism for IBS has increased exponentially in recent years. This study was designed to summarize the Chinese herbal medicine (CHM) that potentially exert protective effects against IBS through inhibition of intestinal immune activation.
View Article and Find Full Text PDFNetwork pharmacology is an interdisciplinary field that utilizes computer science, technology, and biological networks to investigate the intricate interplay among compounds/ingredients, targets, and diseases. Within the realm of traditional Chinese medicine (TCM), network pharmacology serves as a scientific approach to elucidate the compatibility relationships and underlying mechanisms of action in TCM formulas. It facilitates the identification of potential active ingredients within these formulas, providing a comprehensive understanding of their holistic and systematic nature, which aligns with the holistic principles inherent in TCM theory.
View Article and Find Full Text PDFBehavior, hormone, and gut microbiota change by YYNS intervention in an OVX mouse model.
Front Cell Infect Microbiol
November 2024
Department of Medicine, Hunan University of Chinese Medicine, Changsha, China.
Article Synopsis
- Perimenopause depression disorder (PDD) is common, characterized by depression and symptoms like hot flashes, linked to low estrogen levels, with emerging research tying it to the endocrine-brain-gut-microbiota axis.
- The study used a mouse model to simulate menopausal depression and tested the effects of a traditional Chinese remedy, Yangyin-ningshen formula (YYNS), alongside estrogen (E2) on behavioral and microbiome changes.
- Results indicated that YYNS significantly alleviated depression symptoms, improved microbial diversity, and altered hormone levels in the OVX mice after three weeks, suggesting its potential role in managing PDD.
From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data.
Cancer Biol Med
October 2024
Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
Article Synopsis
- The study aims to create an algorithm that helps identify the key active components in Chinese herbal medicine (CHM), which can be complex and difficult to analyze.
- Using various databases, researchers gathered gene targets and conducted analyses to find core targets linked to specific diseases, ultimately developing the CHM-FIEFP algorithm.
- Testing on the Danggui Sini Decoction (DSD) for gastric cancer revealed that ferulic acid had the highest fitting score, showing similar effects to the entire DSD formula, indicating the algorithm’s effectiveness in pinpointing critical components in CHM.
The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms.
Chin Med
October 2024
Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, No.5 Beixian Ge, Xicheng District, Beijing, 100053, China.
Background: Although the pathogenesis of essential hypertension is not clear, a large number of studies have shown that oxidative stress plays an important role in the occurrence and development of hypertension and target organ damage.
Purpose: This paper systematically summarizes the relationship between oxidative stress and hypertension, and explores the potential mechanisms of Chinese herbal medicine (CHM) in the regulation of oxidative stress in hypertension, aiming to establish a scientific basis for the treatment of hypertension with CHM.
Methods: To review the efficacy and mechanism by which CHM treat hypertension through targeting oxidative stress, data were searched from PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, the Chinese National Knowledge Infrastructure, the VIP Information Database, the Chinese Biomedical Literature Database, and the Wanfang Database from their inception up to January 2024.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!